Back to News
Market Impact: 0.25

SkinHealth's SkinStylus Secures FDA Clearance For Periorbital Wrinkles Across All Skin Types

Regulation & LegislationCompany FundamentalsHealthcare & BiotechProduct Launches

SkinHealth Systems said the U.S. FDA cleared its SkinStylus microneedling device for improving periorbital wrinkles in adults aged 22+ across all Fitzpatrick skin types. The clearance expands the device’s approved use profile, which is supportive for product adoption. No financial guidance or revenue figures were provided.

Analysis

SkinHealth Systems said the U.S. FDA cleared its SkinStylus microneedling device for improving periorbital wrinkles in adults aged 22+ across all Fitzpatrick skin types. The clearance expands the device’s approved use profile, which is supportive for product adoption. No financial guidance or revenue figures were provided.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.35

Ticker Sentiment

SKIN0.70

More News